Thank you to our Foundational and Sustaining members
Bright Health Inc. Announces $500 Million Series E Funding Including Significant Investments by Tiger Global Management, T. Rowe Price Associates, Blackstone, NEA and Bessemer Venture Partners Bind Launches Into the Fully-insured Market Spineology Gets FDA De Novo Grant of Minimally Invasive OptiMesh Expandable Interbody Fusion System Medtronic gains breakthrough nod for VAD driveline Fast Company […]
Blue Cross and Blue Shield of Minnesota Expands Access Statewide To Supportive Care Services From Livio Health Mayo scientists develop mathematical index to distinguish healthy microbiome from diseased Using Predictive Analytics to Target SDoH Interventions During COVID-19 FedEx SenseAware ID device expected to see use for COVID-19 vaccine shipments University of Minnesota R&D expenditures break […]
Mayo’s plasma program shows first signs of COVID-19 benefit University of Minnesota turns natural killer cells against COVID-19 FDA approves new Medtronic neurostim leads Best Buy’s health chief to step down, will remain an advisor as company pursues long-term ambitions Rival drugmakers launch joint trial of medicines for COVID-19 Cantel Medical names new president Walking […]
Envoy Medical Receives FDA Breakthrough Device Designation for its Fully Implanted Acclaim® Cochlear Implant Study design for CVRx device can serve as heart failure model: JACC editorial Philips ranked as world’s most innovative medtech company in Boston Consulting Group’s Annual Report Takeda Receives U.S. FDA Approval to Manufacture ENTYVIO® (vedolizumab) Drug Substance at Manufacturing Facility […]
U.S. News and World Report Names Mayo Nation’s Top Hospital Medtronic gets $337 million from Blackstone for diabetes devices Abbott FreeStyle Libre 2 iCGM FDA cleared for use in adults and children At the Edge of Possible Cardiovascular Systems’ offering nabs $143.7m Mayo Clinic, NASA team up to test AI algorithm on colorectal cancer Boston […]
Via Takeda To our valued patients, customers and other stakeholders, As the COVID-19 crisis continues to unfold, Takeda’s Patient Assistance Response team is working around the clock to help ensure that the people who need our medicines and treatments can continue to access them safely and without interruption. Consistent with our commitment to prioritizing patients’ […]
Via Takeda “Experts from the world’s leading plasma companies have come together to create a new alliance aimed at treating the new coronavirus. The CoVIg-19 Plasma Alliance is an initiative to accelerate the development of a potential treatment for COVID-19. The first phase of the Alliance is collecting plasma at licensed plasma collection centers across […]
Via Takeda Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one, unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobulin medicine with the potential to treat individuals with […]
Via The Street “Japanese drug maker Takeda is planning to use an old therapy technology for a new disease, Covid-19. The company is developing a plasma-derived therapy, dubbed TAK-888, that would be similar to plasma-based treatments previously used on other severe acute viral infections, including during the Ebola crisis, that is based on technology believed to […]
COVID-19: How Mayo Clinic is preparing to respond to a potential pandemic Vice President Mike Pence visits 3M on coronavirus tour Takeda Pharma says it is developing coronavirus drug Coronavirus – How Health Plans Can Help Their Members Stay Safe from COVID-19 Right Now CE Mark for Abbott’s FlexNav Delivery System for TAVI Valve Sanofi […]